Vital Farms (NASDAQ:VITL) Issues Quarterly Earnings Results

Key Points

• Vital Farms reported a Q1 GAAP EPS loss of $0.03 versus a consensus $0.09 (a miss), while revenue beat at $187.2M, up about 15% year‑over‑year.
• Management lowered FY‑2026 guidance to $775M–$800M in net sales and $0–$10M adjusted EBITDA, warned Q2 will be the trough and cited ~$32M of short‑term supply costs that will cause negative free cash flow, while enacting cost/cash actions including ~$75M less CapEx and exiting the butter business.
• The stock plunged to about $9.52 on heavy volume and analyst price‑target cuts, though MarketBeat shows a consensus "Moderate Buy" target near $32.42.

Vital Farms (NASDAQ:VITL - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.12), FiscalAI reports. The company had revenue of $187.16 million during the quarter, compared to analyst estimates of $182.40 million. Vital Farms had a net margin of 8.73% and a return on equity of 20.69%. The firm's quarterly revenue was up 15.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.37 EPS.

Here are the key takeaways from Vital Farms' conference call:

• The company lowered full-year guidance to $775M–$800M in net sales and $0–$10M adjusted EBITDA, expects Q2 to be the trough, and calls 2026 a "low watermark" for margins.
• Management is actively narrowing retail price gaps (e.g., cut a top-10 customer's gap from ~35% to ~25%), which drove an 18% volume lift in two weeks, and expects to add 20–30 TDPs (15–25%) in 2026 from distribution wins.
• Cash and cost actions include ~$4M annual ECS labor savings, ~10% reduction in remote headcount, pausing/scheduling CapEx (reducing 2026 CapEx by ~$75M), and exiting the butter business to free ~$25M cash and improve gross margin 150–200 bps in 2027.
• Short-term supply-management costs are material — management estimates ~$32M (excess breaker/low‑revenue channels and farmer contract amendments) concentrated in Q2, leading to negative free cash flow and planned draw on the revolver despite $51.4M cash and no debt.

Vital Farms Stock Performance

NASDAQ:VITL traded down $2.48 during midday trading on Thursday, reaching $9.52. The stock had a trading volume of 19,552,914 shares, compared to its average volume of 2,808,424. Vital Farms has a 1-year low of $8.40 and a 1-year high of $53.13. The firm's fifty day simple moving average is $14.91 and its 200-day simple moving average is $25.49. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.16 and a quick ratio of 1.61. The stock has a market capitalization of $407.93 million, a P/E ratio of 6.61 and a beta of 1.20.

Insiders Place Their Bets

In other news, Director Karl Khoury bought 5,000 shares of the stock in a transaction that occurred on Monday, March 9th. The shares were acquired at an average cost of $18.45 per share, for a total transaction of $92,250.00. Following the purchase, the director owned 119,789 shares of the company's stock, valued at $2,210,107.05. This represents a 4.36% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder Matthew Ohayer sold 20,000 shares of the firm's stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $20.33, for a total transaction of $406,600.00. Following the completion of the transaction, the insider owned 6,321,190 shares in the company, valued at $128,509,792.70. The trade was a 0.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 21.30% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of VITL. Royal Bank of Canada grew its stake in Vital Farms by 89.2% in the 1st quarter. Royal Bank of Canada now owns 19,381 shares of the company's stock valued at $591,000 after buying an additional 9,136 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Vital Farms by 5.8% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,057 shares of the company's stock valued at $611,000 after buying an additional 1,108 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in Vital Farms by 3.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 415,420 shares of the company's stock valued at $12,658,000 after buying an additional 13,397 shares during the last quarter. Woodline Partners LP acquired a new position in Vital Farms in the 1st quarter valued at $1,073,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Vital Farms by 1.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 89,893 shares of the company's stock valued at $2,739,000 after buying an additional 1,198 shares during the last quarter. 98.59% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on VITL. Needham & Company LLC dropped their price objective on shares of Vital Farms from $35.00 to $20.00 and set a "buy" rating on the stock in a research note on Friday, March 27th. Zacks Research lowered shares of Vital Farms from a "hold" rating to a "strong sell" rating in a research note on Monday, March 2nd. Telsey Advisory Group decreased their price objective on shares of Vital Farms from $35.00 to $26.00 and set an "outperform" rating for the company in a report on Friday, March 27th. Benchmark cut shares of Vital Farms from a "buy" rating to a "hold" rating in a report on Thursday, February 26th. Finally, DA Davidson reiterated a "neutral" rating and issued a $16.00 price objective (down from $47.00) on shares of Vital Farms in a report on Monday. Eight investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Vital Farms currently has a consensus rating of "Moderate Buy" and a consensus target price of $32.42.

Vital Farms News Summary

Here are the key news stories impacting Vital Farms this week:

• Positive Sentiment: Revenue beat and growth — Vital Farms reported Q1 revenue of $187.2M, above consensus (~$182.4M) and up ~15% year‑over‑year, showing ongoing top‑line demand for the company’s products. Zacks: Vital Farms Reports Q1
• Neutral Sentiment: Profitability metrics mixed — the company posted a net margin of 8.73% and a return on equity of 20.69%, which indicate underlying profitability despite the quarterly EPS swing; investors can review the company’s press release and slide deck for more detail. Vital Farms Press Release / Slide Deck
• Negative Sentiment: EPS miss — Q1 GAAP EPS was a loss of $0.03 versus a consensus profit estimate of $0.09, a notable swing from $0.37 a year earlier; earnings disappointment increases near‑term downside pressure. Zacks: Q1 EPS Miss
• Negative Sentiment: Guidance shortfall — management trimmed FY‑2026 revenue guidance to roughly $775M–$800M vs. street consensus near $871.6M, a sizable gap that materially weakens forward earnings visibility and likely drove selling. (See company materials linked above for the guidance range.)
• Negative Sentiment: Multiple class‑action suits and investigations — several law firms have filed or announced investigations alleging Vital Farms misled investors (claims reference the May 8, 2025–Feb 26, 2026 class period), and at least one complaint alleges the company concealed ERP implementation disruptions; legal risk and potential future liabilities add to investor uncertainty. Robbins LLP: Class Action Notice Levi & Korsinsky: ERP Allegation

About Vital Farms

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms' supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.